Donald Poirier

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 19

Top Venues

Molecules (Basel, Switzerland)

Journal of medicinal chemistry

Cancers

The Journal of organic chemistry

Université Laval

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université Laval Jul 01 1991

Canada

Professor-Researcher :: Molecular Medicine

Publications

Donald Poirier, Jenny Roy, René Maltais, Cindy Weidmann, Étienne Audet-Walsh
An Aminosteroid Derivative Shows Higher In Vitro and In Vivo Potencies than Gold Standard Drugs in Androgen-Dependent Prostate Cancer Models. Cancers 15 (11) (2023)
René Maltais, Jean-Yves Sancéau, Donald Poirier, André Marette
A Concise, Gram-Scale Total Synthesis of Protectin DX and Related Labeled Versions via a Key Stereoselective Reduction of Enediyne. The Journal of organic chemistry (2023)
Donald Poirier
Description of Chemical Synthesis, Nuclear Magnetic Resonance Characterization and Biological Activity of Estrane-Based Inhibitors/Activators of Steroidogenesis. Molecules (Basel, Switzerland) 28 (8) (2023)
Adrien Djiemeny Ngueta, Jenny Roy, René Maltais, Donald Poirier
Chemical Synthesis and Biological Evaluation of 3-Substituted Estrone/Estradiol Derivatives as 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors Acting via a Reverse Orientation of the Natural Substrate Estrone. Molecules (Basel, Switzerland) 28 (2) (2023)
Adrien Djiemeny Ngueta, Jenny Roy, René Maltais, Donald Poirier
Chemical Synthesis and Biological Evaluation of 3-Substituted Estrone/Estradiol Derivatives as 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors Acting via a Reverse Orientation of the Natural Substrate Estrone. Molecules (Basel, Switzerland) 28 (2) (2023)
Adrien Djiemeny Ngueta, Jenny Roy, René Maltais, Donald Poirier
Chemical Synthesis and Biological Evaluation of 3-Substituted Estrone/Estradiol Derivatives as 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors Acting via a Reverse Orientation of the Natural Substrate Estrone. Molecules (Basel, Switzerland) 28 (2) (2023)
Donald Poirier
Description of Chemical Synthesis, Nuclear Magnetic Resonance Characterization and Biological Activity of Estrane-Based Inhibitors/Activators of Steroidogenesis. Molecules (Basel, Switzerland) 28 (8) (2023)
Adrien Djiemeny Ngueta, Jenny Roy, René Maltais, Donald Poirier
Chemical Synthesis and Biological Evaluation of 3-Substituted Estrone/Estradiol Derivatives as 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors Acting via a Reverse Orientation of the Natural Substrate Estrone. Molecules (Basel, Switzerland) 28 (2) (2023)
Donald Poirier
Description of Chemical Synthesis, Nuclear Magnetic Resonance Characterization and Biological Activity of Estrane-Based Inhibitors/Activators of Steroidogenesis. Molecules (Basel, Switzerland) 28 (8) (2023)
Donald Poirier
Description of Chemical Synthesis, Nuclear Magnetic Resonance Characterization and Biological Activity of Estrane-Based Inhibitors/Activators of Steroidogenesis. Molecules (Basel, Switzerland) 28 (8) (2023)
René Maltais, Jenny Roy, Donald Poirier
Turning a Quinoline-based Steroidal Anticancer Agent into Fluorescent Dye for its Tracking by Cell Imaging. ACS medicinal chemistry letters 12 (5) (2021)
René Maltais, Jenny Roy, Martin Perreault, Sachiko Sato, Julie-Christine Lévesque, Donald Poirier
Induction of Endoplasmic Reticulum Stress-Mediated Apoptosis by Aminosteroid RM-581 Efficiently Blocks the Growth of PC-3 Cancer Cells and Tumors Resistant or Not to Docetaxel. International journal of molecular sciences 22 (20) (2021)
Donald Poirier, Jenny Roy, René Maltais
A Targeted-Covalent Inhibitor of 17β-HSD1 Blocks Two Estrogen-Biosynthesis Pathways: In Vitro (Metabolism) and In Vivo (Xenograft) Studies in T-47D Breast Cancer Models. Cancers 13 (8) (2021)
Donald Poirier, Jenny Roy, René Maltais, Diana Ayan
Antisulfatase, Osteogenic, and Anticancer Activities of Steroid Sulfatase Inhibitor EO-33 in Mice. Journal of medicinal chemistry 62 (11) (2019)
Francisco Cortés-Benítez, Jenny Roy, Martin Perreault, René Maltais, Donald Poirier
A- and D-Ring Structural Modifications of an Androsterone Derivative Inhibiting 17β-Hydroxysteroid Dehydrogenase Type 3: Chemical Synthesis and Structure-Activity Relationships. Journal of medicinal chemistry 62 (15) (2019)
Jean-Yves Sancéau, René Maltais, Donald Poirier, André Marette
Total Synthesis of the Antidiabetic (Type 2) Lipid Mediator Protectin DX/PDX. The Journal of organic chemistry 84 (2) (2018)
Martin Perreault, René Maltais, Jenny Roy, Sylvain Picard, Ion Popa, Nicolas Bertrand, Donald Poirier
Induction of endoplasmic reticulum stress by aminosteroid derivative RM-581 leads to tumor regression in PANC-1 xenograft model. Investigational new drugs 37 (3) (2018)
Tang Li, René Maltais, Donald Poirier, Sheng-Xiang Lin
Combined Biophysical Chemistry Reveals a New Covalent Inhibitor with a Low-Reactivity Alkyl Halide. The journal of physical chemistry letters 9 (18) (2018)
Raphaël Dutour, Jenny Roy, Francisco Cortés-Benítez, René Maltais, Donald Poirier
Targeting Cytochrome P450 (CYP) 1B1 Enzyme with Four Series of A-Ring Substituted Estrane Derivatives: Design, Synthesis, Inhibitory Activity, and Selectivity. Journal of medicinal chemistry 61 (20) (2018)

Donald Poirier.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Donald Poirier